Correlation between Lateralization Index of Adrenal Venous Sampling and Standardized Outcome in Primary Aldosteronism

Correlation between Lateralization Index of Adrenal Venous Sampling and Standardized Outcome in... Abstract Objectives The aim of this study was to investigate the impact of adrenal venous sampling (AVS) lateralization cut-offs on surgical outcomes. Patients and Methods Cosyntropin-stimulated AVS was used to guide surgical management of 377 patients with primary aldosteronism (PA) who were evaluated 6 months after surgery. Main outcome measures The proportion of patients that achieved clinical benefit and complete biochemical success based on the AVS aldosterone lateralization index (LI) was determined. Results Clinical benefit was achieved in 29 of 47 patients with an LI between 2-4, in 66 of 101 with an LI between 4-10, and in 158 of 203 with an LI >10 (P<0.01 for trend). Complete biochemical success was achieved in 27 of 42 with an LI between 2–4, in 60 of 76 with an LI between 4-10, and in 127 of 155 with an LI >10 (P=0.024 for trend). After adjustment for confounders and using those with an LI between 2–4 as a reference, a clinical benefit was associated only with those with an LI >10 (OR 2.30; 95%CI 1.03–5.16); whereas, complete biochemical success was associated with those with an LI between 4–10 (OR 2.83; 95%CI 1.14–7.01) or LI >10 (OR 3.55, 95%CI 1.47–8.55). Conclusions Difference of clinical outcome was relatively small when strict LI diagnostic threshold was used and biochemical cure was sufficiently achieved when an LI >4 was used. Our study by standardized outcome measure validated that an LI >4 is suggest to be appropriate to determine unilateral disease in PA. Copyright © 2018 Endocrine Society This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/). http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of the Endocrine Society Oxford University Press

Correlation between Lateralization Index of Adrenal Venous Sampling and Standardized Outcome in Primary Aldosteronism

15 pages
Read Article

Loading next page...
 
/lp/ou_press/correlation-between-lateralization-index-of-adrenal-venous-sampling-r6YUW5yD4m
Publisher
Endocrine Society
Copyright
Copyright © 2018 Endocrine Society
eISSN
2472-1972
D.O.I.
10.1210/js.2018-00055
Publisher site
See Article on Publisher Site

Abstract

Abstract Objectives The aim of this study was to investigate the impact of adrenal venous sampling (AVS) lateralization cut-offs on surgical outcomes. Patients and Methods Cosyntropin-stimulated AVS was used to guide surgical management of 377 patients with primary aldosteronism (PA) who were evaluated 6 months after surgery. Main outcome measures The proportion of patients that achieved clinical benefit and complete biochemical success based on the AVS aldosterone lateralization index (LI) was determined. Results Clinical benefit was achieved in 29 of 47 patients with an LI between 2-4, in 66 of 101 with an LI between 4-10, and in 158 of 203 with an LI >10 (P<0.01 for trend). Complete biochemical success was achieved in 27 of 42 with an LI between 2–4, in 60 of 76 with an LI between 4-10, and in 127 of 155 with an LI >10 (P=0.024 for trend). After adjustment for confounders and using those with an LI between 2–4 as a reference, a clinical benefit was associated only with those with an LI >10 (OR 2.30; 95%CI 1.03–5.16); whereas, complete biochemical success was associated with those with an LI between 4–10 (OR 2.83; 95%CI 1.14–7.01) or LI >10 (OR 3.55, 95%CI 1.47–8.55). Conclusions Difference of clinical outcome was relatively small when strict LI diagnostic threshold was used and biochemical cure was sufficiently achieved when an LI >4 was used. Our study by standardized outcome measure validated that an LI >4 is suggest to be appropriate to determine unilateral disease in PA. Copyright © 2018 Endocrine Society This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).

Journal

Journal of the Endocrine Society – Oxford University Press

Published: May 24, 2018

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off

Sign up
for free
Start 14 day
Free Trial